Literature DB >> 5424370

Partial purification and properties of urokinase inhibitor from human placenta.

T Kawano, K Morimoto, Y Uemura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5424370     DOI： 10.1093/oxfordjournals.jbchem.a129257

Source DB:  PubMed          Journal:  J Biochem        ISSN： 0021-924X            Impact factor:   3.387


× No keyword cloud information.
  20 in total

1.  Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.

Authors:  B S Knudsen; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model.

Authors:  Bettina Buchthal; Ursula Weiss; Hilmar Bading
Journal:  Mol Ther       Date:  2018-07-23       Impact factor: 11.454

3.  Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.

Authors:  H A Chapman; O L Stone
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

4.  Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition.

Authors:  M B Bernik
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

5.  Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer.

Authors:  H Ito; Y Yonemura; H Fujita; K Tsuchihara; T Kawamura; N Nojima; T Fujimura; H Nose; Y Endo; T Sasaki
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 6.  PAI-1 in tissue fibrosis.

Authors:  Asish K Ghosh; Douglas E Vaughan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

7.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

Authors:  T D Gelehrter; R Sznycer-Laszuk
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Low molecular weight peptides with anti-thrombin and anti-urokinase activity isolated from human maternal and cord blood serum and amniotic fluid.

Authors:  M Uszyński; F K Beller
Journal:  Arch Gynakol       Date:  1976

9.  Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7.

Authors:  Xuan Zhang; Etter Hoang; Warren B Nothnick
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

10.  Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.

Authors:  T M Antalis; M A Clark; T Barnes; P R Lehrbach; P L Devine; G Schevzov; N H Goss; R W Stephens; P Tolstoshev
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.